Atlas Trials

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Clinical trial NCT02614937 · COMPLETED

Trial details

NCT number
NCT02614937
Sponsor
Ohr Pharmaceutical Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Retinal Vein OcclusionMacular Edema
Start date
2013-04-01
Primary completion
2014-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.